| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |